Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Frontiers in Public Health|September 22, 2025
Impact of multiple environmental factors on influenza-like illness in Fujian Province, China, 2015-2023: a multicity studyXiaoyan Yao, Yanhua Zhang, Yuemei Hu, et al.
Human Vaccines & Immunotherapeutics|April 30, 2020
Immunogenicity and safety of an inactivated quadrivalent influenza vaccine: a randomized, double-blind, controlled phase III clinical trial in children aged 6-35 months in ChinaYuemei Hu, Ming Shao, Yuansheng Hu, et al.
Viruses|August 7, 2015
Characterization of Humoral Responses Induced by an H7N9 Influenza Virus-Like Particle Vaccine in BALB/C MiceLi Zhang, Jing Lu, Yin Chen, et al.
Therapeutic Advances in Drug Safety|December 16, 2015
Safety and tolerability of 13-valent pneumococcal conjugate vaccine in healthy Chinese adults, children and infantsFengcai Zhu, Yuemei Hu, Qi Liang, et al.
Human Vaccines & Immunotherapeutics|February 20, 2019
Immunogenicity and safety of a trivalent inactivated influenza vaccine produced in Shenzhen, China versus a comparator influenza vaccine: a phase IV randomized studyYuemei Hu, Kai Chu, Nathalie Lavis, et al.
Human Vaccines & Immunotherapeutics|January 25, 2019
Effect of maternal antibody on the infant immune response to inactivated poliovirus vaccines made from Sabin strainsRong Tang, Kai Chu, Yuansheng Hu, et al.
The Journal of Infectious Diseases|April 9, 2019
Immunogenicity and Safety of a Sabin Strain-Based Inactivated Polio Vaccine: A Phase 3 Clinical TrialYuemei Hu, Jianfeng Wang, Gang Zeng, et al.
Vaccine|September 26, 2018
Safety and immunogenicity of inactivated poliovirus vaccine made from Sabin strains: A phase II, randomized, dose-finding trialKai Chu, Zhifang Ying, Ling Wang, et al.
Open Forum Infectious Diseases|October 30, 2019
Safety and Immunogenicity of Sabin Strain Inactivated Poliovirus Vaccine Compared With Salk Strain Inactivated Poliovirus Vaccine, in Different Sequential Schedules With Bivalent Oral Poliovirus Vaccine: Randomized Controlled Noninferiority Clinical Trials in ChinaYuemei Hu, Kangwei Xu, Weixiao Han, et al.
Human Vaccines & Immunotherapeutics|June 22, 2018
One year immunogenicity and safety of subunit plague vaccine in Chinese healthy adults: An extended open-label studyJialei Hu, Lei Jiao, Yuemei Hu, et al.
Pageof 5